A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
Public ClinicalTrials.gov record NCT07668388. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Efficacy and Safety of Once-weekly Subcutaneous UBT251 in Participants With Type 2 Diabetes - a Dose-finding Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The study is testing UBT251 in participants with type 2 diabetes. The purpose of this clinical study is to find out if UBT251 is effective and safe for treating participants with type 2 diabetes. Participants will either get UBT251, UBT251 placebo, semaglutide, or semaglutide placebo. Which treatment participants get is decided by chance. UBT251 is the treatment being tested and is not yet available for doctors to prescribe, while semaglutide is a medicine used to treat type 2 diabetes that doctors can already prescribe.
Study identification
- NCT ID
- NCT07668388
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 300 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 21, 2026
- Primary completion
- Oct 3, 2027
- Completion
- Nov 14, 2027
- Last update posted
- Aug 9, 2026
2026 – 2027
United States locations
- U.S. sites
- 25
- U.S. states
- 14
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Flourish Research | Birmingham | Alabama | 35205 | Recruiting |
| Ark Clinical Research | Fountain Valley | California | 92708 | Recruiting |
| Ark Clinical Research | Long Beach | California | 90815 | Recruiting |
| Los Angeles Institute for Metabolic Research | Los Angeles | California | 90015 | Recruiting |
| Catalina Research Institute, LLC | Montclair | California | 91763 | Recruiting |
| Encore Medical Research LLC | Hollywood | Florida | 33024 | Recruiting |
| South Broward Research LLC | Miramar | Florida | 33027 | Recruiting |
| Encore Medical Research of Weston | Weston | Florida | 33331 | Recruiting |
| Midwest Inst For Clin Res | Indianapolis | Indiana | 46260 | Not yet recruiting |
| Cotton O'Neil Diabetes & Endocrinology | Topeka | Kansas | 66606 | Recruiting |
| MD Medical Research | Oxon Hill | Maryland | 20745 | Recruiting |
| PharmQuest | Greensboro | North Carolina | 27408 | Not yet recruiting |
| KDCILM, LLC & Accellacare US, Inc. | Wilmington | North Carolina | 28401 | Recruiting |
| Plains Clinical Research Center, LLC_Fargo | Fargo | North Dakota | 58104 | Not yet recruiting |
| Preferred Primary Care Physicians, Inc. | Uniontown | Pennsylvania | 15401 | Recruiting |
| Monroe Biomedical Research, LLC | North Charleston | South Carolina | 29406 | Recruiting |
| LifeDoc Health | Memphis | Tennessee | 38115 | Recruiting |
| IMA Clinical Research | Austin | Texas | 78745 | Recruiting |
| Private Practice - Dr. Laila A. Hassan | Houston | Texas | 77089 | Recruiting |
| Radiance Clinical Research | Lampasas | Texas | 76550 | Recruiting |
| Quality Research Inc | San Antonio | Texas | 78209 | Recruiting |
| Tekton Research Inc | San Antonio | Texas | 78258 | Recruiting |
| Consano Clin Res-Shavano Park | Shavano Park | Texas | 78231 | Recruiting |
| Chrysalis Clinical Research | St. George | Utah | 84790 | Recruiting |
| The Vancouver Clinic | Vancouver | Washington | 98664 | Not yet recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 45 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07668388, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 9, 2026 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07668388 live on ClinicalTrials.gov.